Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Acquisitions (2020 - 2024)

Standard Biotools (LAB) has disclosed Acquisitions for 3 consecutive years, with -$278.6 million as the latest value for Q4 2024.

  • Quarterly Acquisitions changed N/A to -$278.6 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $1.4 million through Dec 2024, changed N/A year-over-year, with the annual reading at $1.4 million for FY2024, N/A changed from the prior year.
  • Acquisitions for Q4 2024 was -$278.6 million at Standard Biotools, down from $280.0 million in the prior quarter.
  • The five-year high for Acquisitions was $280.0 million in Q1 2024, with the low at -$278.6 million in Q4 2024.